EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Luspatercept ameliorates disease phenotype and complications in the Townes mouse model of sickle cell disease

Maiko Sezaki, Tian Li, Mingzhe Pan, Zhihong Wang, Jie Bai, Justin G Horowitz, Julia Z Xu, Gang Huang

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci197706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Maiko Sezaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Recombinant Fusion Proteins, Immunoglobulin Fc Fragments. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH R01, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preclinical data demonstrating that luspatercept mitigates vaso-occlusive and anemia-related complications in the Townes sickle cell model provide a strong rationale for its evaluation in SCD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellRecombinant Fusion ProteinsImmunoglobulin Fc FragmentsAnimalsDisease Models, AnimalMiceHumansVaso-Occlusive CrisesPhenotypeActivin Receptors, Type II

Stichwörter der Autor:innen

HematologyHematopoietic stem cellsImmunology

Substanzen

Recombinant Fusion ProteinsluspaterceptImmunoglobulin Fc FragmentsActivin Receptors, Type II

Autor:innen und Institutionen

  • Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, Texas, USA.
  • Department of Hematology, Fujian Provincial Hospital, Fuzhou, China.
  • Department of Pharmacy Services, UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, USA.
  • Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, UT Health San Antonio, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas, USA.

Förderung

  • NCI NIH HHS
  • NIH R01
  • U.S. Department of Defense
  • P30 Cancer Center Support Grant

Zitieren

APA

Sezaki, M., Li, T., Pan, M., Wang, Z., Bai, J., Horowitz, J. G., Xu, J. Z., & Huang, G. (2026). Luspatercept ameliorates disease phenotype and complications in the Townes mouse model of sickle cell disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci197706

Vancouver

Sezaki M, Li T, Pan M, Wang Z, Bai J, Horowitz JG, et al. Luspatercept ameliorates disease phenotype and complications in the Townes mouse model of sickle cell disease. Journal of Clinical Investigation. 2026. doi:10.1172/jci197706

BibTeX
@article{Sezaki2026,
  author = {Sezaki, Maiko and Li, Tian and Pan, Mingzhe and Wang, Zhihong and Bai, Jie and Horowitz, Justin G and Xu, Julia Z and Huang, Gang},
  title = {Luspatercept ameliorates disease phenotype and complications in the Townes mouse model of sickle cell disease},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci197706}
}
Kostenlos starten →